Pregnant cattle were either vaccinated subcutaneously with (i) a suspension of purified Escherichia coli K99 pili, (ii) a Formalin-killed whole cell bacterin containing enterotoxigenic E. coli strain B44 (09:K30;K99:H-), or (iii) a bacterin containing six different strains of bovine enterotoxigenic E. coli (multiple-strain bacterin), or were left as nonvaccinated controls. After birth, calves were allowed to nurse their dams and, at 12 to 14 h of age, were challenged orally with 1011 cells of enterotoxigenic E. coli strain B44. Colostral antibody titers were determined against K99, K30, and 09 antigens of B44. In the nonvaccinated control group, 9 of 10 calves developed diarrhea and died within 24 to 72 h. Similarly, all six calves in the multiple-strain bacterin group developed diarrhea and four died. In contrast to calves in the two groups mentioned above, calves nursing cows vaccinated with either purified K99 or the homologous whole cell bacterin were protected against fatal diarrhea. There was a highly significant correlation (P < 0.0005) between protection against fatal diarrhea and K99, but not K30 or 09 colostral antibody titers. Vaccination of cows with either purified pili or whole cell preparations containing sufficient K99 antigen may provide a means of preventing enterotoxigenic colibacillosis in calves.
It is generally accepted that colonization of the mucosal surface of the small intestine by enterotoxigenic Escherichia coli (ETEC) occurs without tissue invasion and is a necessary early stage in the pathogenesis of diarrhea (14) . Colonization appears to be dependent upon the ability of the involved strains to adhere to the villus epithelium. Attachment to the epithelial cell surface is mediated by pili known as: the K99 antigen on bovine, ovine, and some porcine ETEC (2, 15, 16, 19, 24, 26) ; K88 and 987P antigens on porcine ETEC (12, 13, 21) ; and fimbriae (3), referred to as colonization factor antigens I and II, on human ETEC (5-7). These pili and fimbriae, which are quite distinct from the classical polysaccharide capsular K antigens, are composed primarily of protein and are serologically unrelated to each other (2a, 10, 27) .
Several earlier studies showed that immunization of pregnant cows with whole cell bacterins containing ETEC prevented fatal diarrhea in nursing calves (18, 20) . However, the antigenic components) of the bacterial cell which stimulates the formation of protective colostral antibody has not been clearly defined. Myers found a correlation between protection against diarrhea in calves and the level of passive antibody against the polysaccharide K30, but not the K99 or 09 antigens, of ETEC strain B44 (09:K30; K99:H-). In contrast, lacteal immunity against K99, K88, and 987P pili prevented severe diarrhea and death in suckling piglets experimentally challenged with ETEC possessing the homologous colonization factor (12a, 17, 22, 25 Challenge inoculation. Studies carried out by others on the efficacy of E. coli vaccines were hampered by the inability to consistently reproduce severe enterotoxigenic colibacillosis in colostrum-fed calves (8, 19) . Therefore, preliminary experiments were done by using several different strains of bovine ETEC cultured on different media to challenge calves at various ages. By using the following method, we were able to consistently reproduce fatal enterotoxigenic colibacillosis in colostrum-fed calves, which was characterized by the presence of large numbers of ETEC attached to the intestinal mucosa (S. D. Acres and J. E. C. Bellamy, Am. J. Vet. Res., in press). ETEC strain B44 previously cultured on Trypticase soy agar slants was subcultured every 24 h in Trypticase soy broth. When needed for challenge, broth cultures were seeded onto the surface of Minca agar containing 1% IsoVitaleX (10) (BBL) and grown at 370C for 10 h. The bacterial growth was washed off the surface of the agar, suspended in PBS, and diluted to the desired concentration. The inoculum was administered into the back of the mouth from a 20-ml syringe when the calves were 12 to 14 h old. Initially, all calves were inoculated with 60 ml of PBS suspension containing 6 x 10" viable B44. Later, when it became apparent that the MSB was not protecting calves challenged with that dose, nine calves were challenged with 30 ml of suspension containing 3 X 101" viable B44.
Collection of samples and clinical observations. Lacteal secretions were collected from each cow at parturition before the calf had nursed. Whey was prepared by using commercial renin and stored at -20°C until used for measurement of antibody titers.
Calves were examined at challenge, 6, 12, and 24 h postchallenge (PC), and then daily until 10 days of age. At each examination, fecal consistency and the degree of dehydration and of depression were recorded and used to determine a clinical score which ranged in value from 0 to 3 as follows: 0 = no diarrhea, dehydration, or depression; 1 = transient softness of feces or watery diarrhea which resulted in a loss of s4% of body weight at challenge (BW); 2 = diarrhea accompanied by a loss of 4 to 11% BW and depression; 3 = diarrhea accompanied by a loss of >11% BW and death. Calves were weighed at challenge and then 12 h and 1, 2, 3, 5, and 10 days PC. Serology. Whey prepared from colostrum collected at parturition was examined for antibodies to K99, K30, and 09 antigens. Antibody titers against K99 were determined by a solid-phase radioimmunoassay which will be reported in detail elsewhere. Briefly, rabbit anti-bovine immunoglobulin G (RABIgG) was prepared and labeled with '25I by the chloramine-T method of Greenwood et al. (9) The K99 titers in cows in the HWCB group averaged approximately one-half of those in the purified K99 group but were still significantly higher than in the control cows. In addition, K30 and 09 antibody titers were increased in cows in this group as compared to those in the control group. The MSB either failed to stimulate, or stimulated only low levels of antibody against all three antigens.
There was a highly significant correlation between the clinical response of the calves after challenge and the colostral K99 antibody titer in their dams. Only 1 of 16 (6.3%) calves nursing dams with K99 titers greater than 1,000 died, whereas 12 of 15 (80.0%) calves nursing dams with K99 titers of 1,000 or less died of severe diarrhea after challenge (X2 = 14.40; P < 0.0005) ( Table 2 ). There was no statistical correlation between the clinical response of calves and either K30 or 09 colostral antibody titers. DISCUSSION Immunization of pregnant cows can be used to stimulate the development of lacteal immunity against experimentally induced and naturally occurring colibacillosis in calves. Myers demonstrated that colostral antibody against the A-type polysaccharide or capsular K30, but not the somatic 0 antigen of ETEC strain B44, prevented diarrhea in calves experimentally challenged with the homologous organism (18) . No attempt to demonstrate cross-protection between different capsular K antigens of ETEC has been reported. Since a variety of different capsular K antigens occur on bovine ETEC (19, 24) , a vaccine based on developing immunity to these antigens may have to contain capsular components from several different serotypes to provide protection against a wide variety of ETEC strains.
An alternative approach to that described above would be to develop immunity to a com-VOL. 25, 1979 (19, 24) .
Second, it plays a vital role in the pathogenesis of the disease by allowing the ETEC to adhere to the intestinal mucosa and proliferate to abnormally high numbers (12, 26 INFECT. IMMUN.
-e nity against K99, K88, and 987 pili prevented severe diarrhea and death in piglets experimentally challenged with porcine ETEC possessing the homologous colonization factor (17, 12a, 22, 25) . Third, the antigen can be purified by using current technology (11) .
The data presented here indicate that lacteal immunity against the K99 antigen prevented severe diarrhea and death in calves experimentally challenged with ETEC strain B44. Twelve of 15 (80.0%) calves nursing cows with colostral K99 antibody titers <1,000 developed severe diarrhea and died after challenge, whereas only 1 of 16 (6.3%) calves nursing cows with titers >1,000 died (P < 0.005). In addition, the colostrum of nonvaccinated control cows did not contain antibody to K99, and 9 of 10 (90%) calves succumbed to fatal diarrhea within 72 h PC. On the other hand, the colostrum ofcows vaccinated with purified K99 contained high levels of K99 antibody, no K30 antibody, and low levels of 09 antibody which did not differ from levels seen in control cows. In this group, all of nine (100%) calves were protected against fatal diarrhea.
In contrast to the above, there was no statistical correlation between protection against fatal diarrhea and the levels of either K30 or 09 colostral antibody which occurred in this study. However, the contribution of these antibodies to protection in the HWCB group cannot be eliminated from consideration because, in most cases, colostrum which contained increased antibody titers to these two antigens also contained increased titers to K99. Six of nine calves in the HWCB group, as compared to only two of nine calves in the K99 group, did not develop even a mild diarrhea after challenge. Since the GMT of K99 antibody in the HWCB group was less than half that in the K99 group, it is likely that K30 or 09 antibody, in addition to K99 antibody, contributed to protection. Other studies showed that K30 but not 09 antibody prevented diarrhea caused by strain B44 (18) . Since the K30 titers observed in this study were quite low, it is possible that higher titers could be protective even in the absence of K99 antibody.
The findings reported here are consistent with the hypothesis that K99 antigen is a necessary virulence attribute of bovine ETEC and that lacteal immunity against this pilus prevents diarrhea, probably by blocking adhesion of the bacteria to the intestinal mucosa. Purified or semi-purified K99, K88, and 987 pili as well as bacterins containing pilus-positive whole cells have now been shown to be safe and effective vaccines against enterotoxigenic colibacillosis in suckling calves and piglets (12a, 17-20, 22, 23, 25) . Additional studies are required to determine which type of preparation will be most useful.
